Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Advocate for Prompt Vasculitis Diagnosis & Treatment

Carina Stanton  |  August 28, 2018

If possible, Dr. Kermani says referring patients to an academic center with expertise in the care of vasculitis can allow patients access to opportunities to participate in research or new therapies. She notes you don’t have to be at an academic center to educate colleagues and other health professionals or to learn. She says, “An open dialogue and discussion with other members of the patient care team is an enriching experience and broadens our perspective.”

4. Stay Current with Treatment Options
For any rheumatic disease, including vasculitis, keeping up with the latest clinical trials research can help in tailoring the appropriate treatment plan for the patient, Dr. Kermani shares. Although good clinical trial data exist for some forms of vasculitis, such as anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, further research is needed for many.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Our efforts can [affect] patient lives in a profound way,” Dr. Kermani stresses. “Recognizing our limitations and reaching out to colleagues when we are facing challenges to discuss things is also a very important way we advocate for our patients.”


Carina Stanton is a freelance science journalist in Denver.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. The American College of Rheumatology. Diseases & conditions: Vasculitis. 2017.

Stay Tuned

The ACR is currently developing guidelines for many forms of vasculitis. Learn more.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:Awarenesspatient advocacyVasculitis

Related Articles

    Updates on Giant Cell Arteritis

    March 19, 2018

    SAN DIEGO—Recent research tells us more about giant cell arteritis (GCA) to help rheumatologists more accurately diagnose and effectively treat patients with this type of vasculitis. On Nov. 6 at the ACR/ARHP Annual Meeting, three experts explored the latest findings on GCA pathogenesis, diagnostic approaches, imaging modalities and growing treatment options. GCA: What’s Really Happening?…

    Bernard Chantal / shutterstock.com

    Diagnostic Challenges of MIS-C

    May 12, 2022

    During the peak of the coronavirus pandemic in Washington, D.C., we were asked to evaluate a 14-year-old boy admitted to the pediatric hospitalist service. He had been healthy until two weeks before, when he noted a sore throat, and soon after he developed fevers and rashes without congestion, shortness of breath, conjunctivitis or swollen lymph…

    ilusmedical / shutterstock.com

    The State of Clinical Research in Vasculitis: 2021

    January 19, 2021

    It is an exciting time in the world of vasculitis research. More clinical studies and trials are being conducted now than at any time in history. In the past ten years, four drugs have been approved by the U.S. Food & Drug Administration (FDA) and other regulatory agencies specifically for the treatment of vasculitis: Rituximab…

    Large Vessel Vasculitis Outcome Measures: An Update from OMERACT

    March 19, 2019

    In ongoing work to validate data-driven outcome tools for clinical investigation in large vessel vasculitis, an international team of rheumatologists from the Outcome Measures in Rheumatology (OMERACT) Vasculitis Working Group has published a report on subclinical disease activity and patient perspectives on therapy response…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences